Anna Turkova is a research clinician at the MRC Clinical Trials Unit at UCL and a Consultant Paediatrician at the Great Ormond Street Hospital, London. Anna is a study physician in several large international paediatric HIV and TB trials and observational multi-centre studies (e.g. ODYSSEY, SHINE, EPPICC). She is a Chief Investigator of the D3 trial, a multi-country randomised controlled trial comparing DTG/3TC vs. Standard of Care in virologically suppressed children and a Scientific Coordinator of the Russian European Alliance for Research among Women and Children affected by HIV, TB and HCV (REACH). She has been working with Penta ID since 2011, and has been teaching on Penta training courses in Eastern and Western Europe, Central Asia and Africa. Anna is one of the authors of the Penta Guidelines for Treatment of Paediatric HIV 2015-2021. She is a member of WHO HIV Guidelines Development Group, WHO-led Paediatric Antiretroviral Working Group (PAWG) and Paediatric Antiretroviral Drug Optimisation (PADO).
